Related Experiment Video
Updated: May 6, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Prostate MRI: can we do without DCE sequences in 2013?
P Puech1, A Sufana-Iancu, B Renard
1Department of Uroradiology, Lille Hospital, 1, rue Michel-Polonovski, 59037 Lille cedex, France; University of Lille Nord de France, Lille 59800, France; Inserm U703, 59120 Loos, France.
Abstract:
Multiparametric MRI (mp-MRI) of the prostate currently provides stable and reproducible performances. The usefulness of dynamic contrast-enhanced (DCE) sequences is currently challenged, as they sometimes only confirm what has already been observed on diffusion-weighted imaging (DWI) and require the additional purchase of a contrast agent. Eliminating these sequences may help accelerate the use of MRI in addition to, or in lieu of, prostate biopsies in selected patients. However, many studies show that these sequences can detect lesions invisible on T2-weighted and diffusion-weighted images, better assess cancer extension and aggressiveness, and finally help detecting recurrence after treatment. We present the various applications of dynamic MRI and discuss the possible consequences of its omission from the current protocol.
Insights
Dynamic contrast-enhanced (DCE) MRI sequences for prostate cancer detection are debated. While potentially redundant, they offer unique insights into lesion visibility, cancer staging, and recurrence detection, crucial for treatment decisions.
Area of Science:
- Radiology
- Oncology
- Medical Imaging
Background:
- Multiparametric MRI (mp-MRI) is a stable tool for prostate cancer assessment.
- Dynamic contrast-enhanced (DCE) sequences in mp-MRI are under scrutiny due to potential redundancy with diffusion-weighted imaging (DWI) and contrast agent costs.
Purpose of the Study:
- To evaluate the role and necessity of DCE sequences within current prostate MRI protocols.
- To discuss the implications of omitting DCE sequences for prostate cancer diagnosis and management.
Main Methods:
- Review of existing literature on the applications of dynamic MRI in prostate cancer.
- Analysis of the unique contributions of DCE sequences compared to T2-weighted and DWI sequences.
- Discussion of the impact of DCE sequence omission on clinical practice.
Main Results:
- DCE sequences can identify lesions not visible on T2-weighted and DWI.
- These sequences improve the assessment of prostate cancer extent and aggressiveness.
- DCE MRI aids in detecting post-treatment recurrence.
Conclusions:
- Despite challenges, DCE sequences provide valuable, unique information in prostate MRI.
- Omitting DCE sequences may hinder comprehensive cancer evaluation and recurrence detection.
- Careful consideration is needed before removing DCE from prostate MRI protocols.
More Related Videos
Related Concept Videos
Magnetic Resonance Imaging
Imaging Studies IV: Magnetic Resonance Imaging
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Imaging Studies for Cardiovascular System IV: CMRI

